CircuLex S100A9/MRP14 ELISA Kit

CircuLex S100A9/MRP14 ELISA Kit.

Specifications:

Components

  • Microplate
  • 10xWash Buffer
  • Sample Dilution Buffer
  • Standard Dilution Buffer
  • Human S100A9 Standard
  • HRP conjugated Detection Antibody
  • Substrate Reagent
  • Stop Solution

Description

The CircuLex Research Product S100A9/MRP14 ELISA Kit is used for the quantitative measurement of human S100A9/MRP14 in serum, plasma and other biological media. It can be used for 96 Assays.

Target: S100A9/MRP14
Product Type: ELISA Kit
Size: 96 Assays
Application: ELISA
Research Area / Disease: Immunology, Neuroscience
Sensitivity: better than 6.55 pg/ml of sample.
Measurement Range: Dilution factors need to be taken into consideration in calculating the human S100A9/MRP14 concentration. Results exceeding human S100A9/MRP14 level of 16 ng/ml should be repeated with diluted samples.
Regulatory Statement: For Research Use Only. Not for use in diagnostic procedures.

Citations

  1. Shield-Artin KL et al. Identification of ovarian cancer-associated proteins in symptomatic women: a novel method for semi-quantitative plasma proteomics. Proteomics Clinical Applications. 6: 170-81. 2012
  2. Mangé A et al. Elevated concentrations of milk β2-microglobulin are associated with increased risk of breastfeeding transmission of HIV-1 (Vertical Transmission Study). J Proteome Res. 12, 5616-25 (2013),
  3. Saito T et al. Distinct expression patterns of alveolar “alarmins” in subtypes of chronic lung allograft dysfunction. Am J Transplant. 14, 1425-32 (2014)
  4. Xu D et al. Serum protein S100A9, SOD3 and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS. PROTEOMICS.  15, 58–67 (2015)
  5. Fang WY et al. Elevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macrophage recruitment and interleukin-6 production. Oncotarget 6, 28401-24 (2015)
  6. Cluzeau T et al. Pro-inflammatory proteins S100A9 and tumor necrosis factor-α suppress erythropoietin elaboration in myelodysplastic syndromes. Haematologica 102, 2015-2020 (2017)
  7. Schaub R et al. The immune response to sub-clinical mastitis is impaired in HIV-infected women. J Transl Med. 16, 296 (2018)

References

  1. Odink, K. et al. (1987) Nature 330, 80-82.
  2. Kerkhoff, C., Klempt, M. & Sorg, C. (1998) Biochim. Biophys. Acta 1448, 200-211.
  3. Sorg, C. (1992) Behring Inst. Mitt. 91, 126-137.
  4. andez-Rodriguez, J., Sanchez, M., Vogl, T., Cid, M. C., and Roth, J. (2004) J. Pathol. 204, 311–316
  5. Nacken, W., Roth, J., Sorg, C., and Kerkhoff, C. (2003) Microsc. Res. Tech. 60, 569–580
  6. Foell, D., Frosch, M., Sorg, C., and Roth, J. (2004) Clin. Chim. Acta. 344, 37–51
  7. Van den Bos, C., Roth, J., Koch, H.G., Hartmann, M. & Sorg, C. (1996) J. Immunol. 156, 1247–1254.
  8. Roth, J., Goebeler, M., Klempt, M., Hartmann, M. & Sorg, C. (1997) J. Biol. Chem. 272, 9496–9502.
  9. Bjork, P. et al. (1997) PLoS Biol. 7, e1000097, 2009
Code CY-8062
Product Type ELISA Kit
Size 96 Assays
Application ELISA
Price
$593.74
Qty: